Tags |
|
|
Links |
|
|
Digg It - Medical Billing - Enteral Nutrition Billing
In the world of medical billing, there is a sub domain all to itself. It is called enteral nutrition. Once upon a time, this was something that would
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
have never been considered to be billable, which is part of the reason that this particular sub domain has its very own CMN. To understand how the CM
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
works, we first have to know a little something about enteral nutrition itself and what it is.
In modern times, it has been determined that there are
In modern times, it has been determined that there are
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
people who are ill because they don't get the right kind of nutrition. Years ago, we weren't so health conscious. The 60s saw the days of white bread
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and preservatives and nobody even knew what the word fiber stood for. Health food stores were the exception rather than the norm. Then, suddenly and
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ithout much warning, people started getting very sick and coming down with diseases that we were able to determine were directly related to nutrition.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
Over time, we began to take nutrition more seriously and started to pay more attention to what we were eating.
In the early days of medical billing, i
In the early days of medical billing, i
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
was almost impossible for a doctor to prescribe nutrition supplements for a patient and expect to be able to bill for them. It was just unheard of.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ou have to understand that in the early days of modern medicine, it was just that. Medicine. The thought of treating anything with food was not even
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
consideration. Those days are long gone. Today, enteral nutrition is not only billable, but it is also very big business for the medical profession.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
This serves a multitude of purposes.
For starters, it gives the physicians another source of income. Being able to bill a patient for something that
For starters, it gives the physicians another source of income. Being able to bill a patient for something that
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
years ago didn't exist is certainly a welcome addition. Aside from that, there is the revenue for the enteral nutrition manufacturers themselves. Pr
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ducts like Enfomil and Similac are big business. Of course there is the additional revenue for the billers and the companies who make forms for the en
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
eral products.
Are their problems with enteral nutrition and enteral billing? As with anything else in the medical billing industry, of course there
Are their problems with enteral nutrition and enteral billing? As with anything else in the medical billing industry, of course there
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
re problems. For one thing, we are dealing with products which, though they are not drugs, can interact with drugs that the patient may be taking or j
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
st flat out not agree with the patient at all and make the patient ill. Some patients have very violent reactions to many enteral nutrition products.
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
Nausea and even vomiting are not uncommon. Sometimes it takes a while to find a product that the patient can tolerate.
On the billing end, there is a
On the billing end, there is a
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ways all the red tape involved with determining if the patient is eligible to get enteral nutrition and if so, how much are they supposed to get per da
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
and how much the carrier will allow to be billed per day. Yes, they dish this stuff out by the spoonful, literally, which makes billing enteral produ
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ts a real pain.
In our next installment on medical billing, we're going to cover the GE0 record CMN, which is specifically designed for enteral billin
In our next installment on medical billing, we're going to cover the GE0 record CMN, which is specifically designed for enteral billin
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/2271/diggit-Medical-Billing--Enteral-Nutrition-Billing.html">Medical Billing - Enteral Nutrition Billing</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/2271/diggit-Medical-Billing--Enteral-Nutrition-Billing.html]Medical Billing - Enteral Nutrition Billing[/url]
Related Articles:
Fundamentals For Financial Success
Bookmark it:
|